创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

Advanced Search

column
Opportunities and Challenges for Global New Drug Submission and Clinical Development after China's Accession to ICH
ZHANG Mingping, LI Changqing
2019, 43(12): 884-891.
Abstract PDF
U.S. FDA's Regulation for Medical Combination Products
MU Lan, DU Xin
2019, 43(12): 892-899.
Abstract PDF
Advantages and Challenges of China's Enterprises Conducting Clinical Trials of Innovative Drugs in both China and US
SHI Yingzi, ZHAO Yang
2019, 43(12): 900-907.
Abstract PDF
Management of Cell Therapy Products in Japan and Its Implications for China
DIAO Yuwei, LIANG Yi
2019, 43(12): 908-913.
Abstract PDF
Discovery of Hypoxic Signaling Mechanism and Advances in Therapy for Renal Anemia
ZHANG Xiaoliang, YANG Xin, TU Yan
2019, 43(12): 914-921.
Abstract PDF
Advances in Research on Mesothelin Targeting Therapeutic Biologics
JIANG Jing, XIN Wei, LI Shenjun, GAO Dong
2019, 43(12): 922-934.
Abstract PDF
Methods for the Performance Evaluation of External Foaming Agents
ZHU Zhiling, REN Xiaolei, XIAO Mengxi, ZHANG Jue
2019, 43(12): 935-941.
Abstract PDF
A Report of New Drugs Research and Development in 2018—Part Ⅱ: Trends and Challenges (Ⅵ)
Graul A I, Dulsat C, Pina P, Cruces E, Tracy M
2019, 43(12): 942-954.
Abstract PDF
An Overview of New Drugs Approved in the US, EU and Japan in October and November 2019
SUN Yousong
2019, 43(12): 955-960.
Abstract PDF